2010-03-31 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: (Original Filing)

[FORM 10-K  For the fiscal year ended December 31, 2009 OR  For the transition period from ________________ to ________________ 001-15643 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 33-0901534 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China N/A (Zip Code) (8629) 8819-3188 Title of] [SERVICES AGREEMENT This SERVICES AGREEMENT (this “Agreement”), dated as of March 30, 2010, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and R. Scott Cramer, an individual, whose address is 1012 Lewis Drive Winter Park, Florida 32789-2225 (“Consultant”). The Company and the Consultant are collectively referred to herein as the “Parties.” RECITALS: A. B. NOW, THEREFORE, in] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010 EX-32.1 9 v179475_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010 EX-32.2 10 v179475_ex32-2.htm] [Contract Registration No. 20096101021102 Technical Cooperation Agreement Name of Project: Cooperative Research of Party A: Xian Tianxing Bio-Pharmaceutical Co., Ltd. (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xi’an, Shaanxi Province, China Date of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to the date when the performances under the terms of the]

By info| 2016-03-01T06:24:36+00:00 March 31st, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-K, 2010-03-31, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: FORM 10-K  For the fiscal year ended

[FORM 10-K  For the fiscal year ended December 31, 2009 OR  For the transition period from ________________ to ________________ 001-15643 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 33-0901534 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China N/A (Zip Code) (8629) 8819-3188 Title of] [SERVICES AGREEMENT This SERVICES AGREEMENT (this “Agreement”), dated as of March 30, 2010, by and between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and R. Scott Cramer, an individual, whose address is 1012 Lewis Drive Winter Park, Florida 32789-2225 (“Consultant”). The Company and the Consultant are collectively referred to herein as the “Parties.” RECITALS: A. B. NOW, THEREFORE, in] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bennet P. Tchaikovsky, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer March 31, 2010 EX-32.1 9 v179475_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bennet P. Tchaikovsky Chief Financial Officer March 31, 2010 EX-32.2 10 v179475_ex32-2.htm] [Contract Registration No. 20096101021102 Technical Cooperation Agreement Name of Project: Cooperative Research of Party A: Xian Tianxing Bio-Pharmaceutical Co., Ltd. (stamp) Party B: Fourth Military Medical University (stamp) China Place of Execution: Xi’an, Shaanxi Province, China Date of Effective: September 23, 2009 Term of Validity: From September 23, 2009 to the date when the performances under the terms of the]

By info| 2016-03-01T06:25:29+00:00 March 31st, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 10-K, 2010-03-31, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

DSWL [DESWELL INDUSTRIES] 8-A12B/A: (Original Filing)

[TABLE OF CONTENTS EX-1.2] [DESWELL INDUSTRIES, INC. CERTIFIED TRUE COPY OF RESOLUTION AMENDMENT OF REGULATION 6.15 l. It was noted that in order to change the quorum requirements for meetings of the members of the Company, it was proposed that the first sentence of Regulation 6.15 of the Companys Articles of Association be deleted in its entirety and the following be substituted in its]

By info| 2016-03-02T04:24:50+00:00 March 31st, 2010|Categories: Chinese Stocks, DSWL, SEC Original|Tags: 0000946936, 2010-03-31, 3089, 8-A12B.A, DSWL, PLASTICS PRODUCTS, NEC|0 Comments

DSWL [DESWELL INDUSTRIES] 8-A12B/A: TABLE OF CONTENTS EX-1.2

[TABLE OF CONTENTS EX-1.2] [DESWELL INDUSTRIES, INC. CERTIFIED TRUE COPY OF RESOLUTION AMENDMENT OF REGULATION 6.15 l. It was noted that in order to change the quorum requirements for meetings of the members of the Company, it was proposed that the first sentence of Regulation 6.15 of the Companys Articles of Association be deleted in its entirety and the following be substituted in its]

By info| 2016-03-02T04:26:06+00:00 March 31st, 2010|Categories: Chinese Stocks, DSWL, Webplus ver|Tags: 0000946936, 2010-03-31, 3089, 8-A12B.A, DSWL, PLASTICS PRODUCTS, NEC|0 Comments

EVK [Ever-Glory International,] 10-K: (Original Filing)

[EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-K For the Year Ended December 31, 2009 TABLE OF CONTENTS Part I 4] [SUBSIDIARIES Perfect Dream Limited, a corporation established under the laws of the British Virgin Islands Goldenway Nanjing Garments Co., Ltd, a wholly foreign-owned limited liability company formed under the laws of the People's Republic of China Nanjing Catch-Luck Garments Co., Ltd., a wholly foreign-owned limited liability company formed under the laws of the People’s Republic of China Nanjing New-Tailun Garments] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this annual report on Form 10-K of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this annual report on Form 10-K of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Edward Yihua Kang Chief Executive Officer EX-32.1 6 v179237_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 7 v179237_ex32-2.htm]

By info| 2016-03-02T18:06:04+00:00 March 31st, 2010|Categories: Chinese Stocks, EVK, SEC Original|Tags: 0000943184, 10-K, 2010-03-31, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

EVK [Ever-Glory International,] 10-K: EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-K For the

[EVER-GLORY INTERNATIONAL GROUP, INC. FORM 10-K For the Year Ended December 31, 2009 TABLE OF CONTENTS Part I 4] [SUBSIDIARIES Perfect Dream Limited, a corporation established under the laws of the British Virgin Islands Goldenway Nanjing Garments Co., Ltd, a wholly foreign-owned limited liability company formed under the laws of the People's Republic of China Nanjing Catch-Luck Garments Co., Ltd., a wholly foreign-owned limited liability company formed under the laws of the People’s Republic of China Nanjing New-Tailun Garments] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this annual report on Form 10-K of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this annual report on Form 10-K of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Edward Yihua Kang Chief Executive Officer EX-32.1 6 v179237_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 7 v179237_ex32-2.htm]

By info| 2016-03-02T18:07:10+00:00 March 31st, 2010|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-K, 2010-03-31, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-K: (Original Filing)

[FORM 10-K x For the fiscal year ended December 31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China 712046 (Zip Code) 011-86-29-33686638 o þ þ o o þ] [Wu Quan Mountain Land Use Transfer Agreement Party A: Village Committee of the Wu Quan Village, Jiang Cun Town, Hu County (Transferor) Party B: Shaanxi Aoxing Pharmaceutical Co., Ltd. (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 EX-32.1 5 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 EX-32.2 6 ex32-2.htm]

By info| 2016-03-03T14:40:52+00:00 March 31st, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-K, 2010-03-31, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-K: FORM 10-K x For the fiscal year ended

[FORM 10-K x For the fiscal year ended December 31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China 712046 (Zip Code) 011-86-29-33686638 o þ þ o o þ] [Wu Quan Mountain Land Use Transfer Agreement Party A: Village Committee of the Wu Quan Village, Jiang Cun Town, Hu County (Transferor) Party B: Shaanxi Aoxing Pharmaceutical Co., Ltd. (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 EX-32.1 5 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 EX-32.2 6 ex32-2.htm]

By info| 2016-03-03T14:42:06+00:00 March 31st, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-K, 2010-03-31, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-K: FORM 10-K x For the fiscal year ended

[FORM 10-K x For the fiscal year ended December31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, Maryland 20-5101287 (State or other jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China 712046 (Zipde)] [Wu Quan Mountain Land Use Transferreement Party A: Villagemmittee of the Wu Quan Village, Jiang Cun Town, Huunty (Transferor) Party B: Shaanxi Aoxing Pharmaceutical (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 ex32-2.htm]

By info| 2016-02-07T17:35:10+00:00 March 31st, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-K, 2010-03-31, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

ALN [American Lorain] 8-K: American Lorain Corporation Reports Results for the Fourth

[American Lorain Corporation Reports Results for the Fourth Quarter and Full Year, 2009 JUNAN COUNTY, China Fourth Quarter 2009 Highlights Revenue for the fourth quarter 2009 was $62.9 million, up 11.0% for the quarter. Operating income was $9.4 million, up 9.1% from the previous year. Net income was $6.3 million, a decrease of 1.5% versus prior year. EPS was $0.24] [____________________________ FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): March 29, 2010 AMERICAN LORAIN CORPORATION Delaware (State of Incorporation) 001-34449 (Commission File No.) 87-0430320 Shandong, China 276600 Beihuan Road (86) 539-7318818 £ £ £ £ Item 2.02. Results of Operations and Financial Condition.]

By info| 2016-03-15T13:56:25+00:00 March 31st, 2010|Categories: ALN, Chinese Stocks, Webplus ver|Tags: 0001117057, 2010-03-31, 2030, 8-K, ALN, CANNED, FROZEN and PRESERVED FRUIT, VEG and FOOD SPECIALTIES|0 Comments